Executive Administrator - Mayo Clinic Comprehensive Cancer Center

Mayo Clinic is top-ranked in more specialties than any other care provider according to U.S. News & World Report. As we work together to put the needs of the patient first, we are also dedicated to our employees, investing in competitive compensation and comprehensive benefit plans.

Benefits

• Medical: Multiple plan options.
• Dental: Delta Dental or reimbursement account for flexible coverage.
• Vision: Affordable plan with national network.
• Pre-Tax Savings: HSA and FSAs for eligible expenses.
• Retirement: Competitive retirement package to secure your future.

Responsibilities

Mayo Clinic is currently seeking a highly skilled and experienced Executive Administrator for the Mayo Clinic Comprehensive Cancer Center (MCCCC). This individual, in partnership with the Executive Director of the MCCCC, is responsible for:

• Strategic and operational planning
• Leadership development
• Staff diversity
• Fiscal management
• Monitoring of operational and performance outcomes of the MCCCC in alignment with Mayo Clinic’s overall strategy

At Mayo Clinic Comprehensive Cancer Center (MCCCC), the mission is to cure cancer. As a leading global authority, MCCCC is transforming cancer research, practice, and education and training with category-of-one data platforms, artificial intelligence (AI), automation, and digital technologies. Through the developing digital front door (My Mayo Clinic) and innovative Cancer Care Beyond Walls (CCBWTM) and Clinical Trials Beyond Walls (CCBWTM) programs, Mayo Clinic discoveries, knowledge, and expertise are accessible to all, within and beyond our walls, at any place or anytime.

Designated as one of the nation’s highest-ranked National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers since 1973, MCCCC is the only NCI Cancer Center with three highly integrated sites—Rochester, Minnesota; Jacksonville, Florida; and Phoenix and Scottsdale, Arizona—treating more than 150,000 unique patients with cancer from across the nation annually. Mayo Clinic and MCCCC also have a fourth health delivery system: Mayo Clinic Health System (MCHS), a community-based primarily rural health care delivery system extending from the Rochester campus through 49 communities in southern Minnesota, western Wisconsin, and northeastern Iowa.

The Executive Administrator also serves as the Enterprise Deputy Director for Administration for the Mayo Clinic NCI P30 Cancer Center Support Grant (CCSG), in partnership with the MCCCC Executive Director who serves as the CCSG Principal Investigator. In this role, the Executive Administrator oversees an administrative team that supports the center’s leadership, faculty, and staff teams who guide each CCSG component. The Executive Administrator works closely with the Center’s Deputy Directors, site-based leaders, and allied health care staff to drive a high-performance collaborative research ecosystem in laboratories, clinics, and communities.

Six Research Programs serve as engines for scientific discovery, translating discoveries to novel diagnostics and therapeutics:

• Cancer Genomics, Signaling, and Metastasis (CGSM)
• Cancer Immunology and Immunotherapeutics (CII)
• Cancer Risk Assessment, Early Detection, Interception (REDI)
• Cancer Prevention, Control, and Survivorship (CPCS)
• Novel Therapeutics and Therapeutic Modalities (NTTM)
• Advanced Clinical Trials and Translational Sciences (ACTS)

Through collaborations and coordination with the Mayo Clinic Research Shield, MCCCC harnesses the power of these Research Programs, seven Translational Science teams, and 15 Disease Groups to drive a highly robust cancer clinical trials program, with distributed and decentralized elements. Center activities are also supported by 15 outstanding Shared Research Resources.

Qualifications

• A master’s degree in business or health care administration is required.
• At least five years of substantial leadership and management experience; 10 years is preferred.
• Experience must include working with physicians, scientific investigators, and allied health staff across a variety of assignments.
• Demonstrated expertise in leadership, management, operations, finance, and communication.
• Broad senior-management experience to coordinate activities across the organization.
• In-depth knowledge of Mayo Clinic’s strategic priorities and a broad understanding of the institution’s strengths and weaknesses relevant to advancing those priorities.
• Scientific expertise and experience in research and clinical trial operations within an NCI-designated cancer center are strongly preferred.

Pay

The minimum starting salary for the position may range from $327,000 to $491,000. This range reflects full-time total base compensation prior to consideration of additional experience or duties. Pay for the selected candidate will vary based on experience, FTE, internal equity, or external market data.

Schedule

• Full Time
• Hours/Pay Period: 80
• Schedule Details: Monday-Friday. Weekend schedule as needed.

Site Description

This is an on-site position based in Rochester, MN.

Mayo Clinic is located in the heart of downtown Rochester, Minnesota, a dynamic city just 75 minutes south of the Twin Cities of Minneapolis and St. Paul. The city is consistently ranked among the best places to live in the United States because of its affordable cost of living, healthy lifestyle, excellent school systems, and exceptionally high quality of life.

The Bold. Forward. Unbound. initiative is a $5 billion, six-year transformation of Mayo Clinic’s downtown Rochester campus, adding approximately 2.4 million square feet across five new buildings. This includes significant new space for integrated in-patient and out-patient cancer care delivery and delivery of new and novel therapeutics. This expansion reimagines care delivery through flexible, future-oriented designs such as adaptable clinical spaces and integrated digital technologies.

Discovery Square is a 16-block district of downtown Rochester, fostering collaborations between biotech industries and Mayo Clinic investigators. One Discovery Square opened in 2019 with infrastructure for wet and dry laboratories and houses the Mayo Clinic Center for Regenerative Biotherapeutics (CRB). CRB is producing several novel cancer therapeutics (gene and virus therapies, cancer vaccines, novel CAR-T agents) which are being tested by Mayo Clinic investigators in clinical trials. Discovery Square is now home to 35 biotechnology companies, including Boston Scientific and Phillips.

In Phoenix/Scottsdale, Arizona, Mayo Clinic is doubling the size of its campus over the next four years, including practice, education, and research activities. A 120-acre biotechnology corridor called Discovery Oasis is currently in development.

In Jacksonville, Florida, the Mayo Clinic campus recently completed a major hospital expansion that includes the opening of the Duan Family Building. This 228,000-square-foot facility introduces the first carbon ion therapy program in the Western Hemisphere, expected to begin treating patients in 2028 pending FDA approval. The Center’s expanded proton radiation therapy program will open in February of 2027. Mayo Clinic has recently acquired 201 acres north of the current 392-acre campus to establish a Healthcare Innovation District and Biotechnology Park: Discovery Coast.